Biomerica (BMRA) Cash from Investing Activities (2010 - 2025)
Biomerica (BMRA) posted Cash from Investing Activities of -$4000.0 for Q1 2025, up 83.33% sequentially from -$24000.0 in Q2 2024, and up 75.0% YoY from -$2285.7 in Q1 2024.
Biomerica (BMRA) Cash from Investing Activities (2010 - 2025) Analysis & Trends
Biomerica has reported Cash from Investing Activities for 16 years, with the latest figure at -$4000.0 in Q1 2025.
- Quarterly Cash from Investing Activities rose 75.0% year-over-year to -$4000.0 in Q1 2025, while the trailing twelve-month figure through May 2025 was -$44000.0 (up 61.74% YoY) and the FY2025 annual result came in at -$37000.0, up 67.83% from the prior year.
- Cash from Investing Activities improved to -$4000.0 in Q1 2025 per BMRA's latest filing, from -$24000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$4000.0 in Q1 2025 and troughed at -$100539.0 in Q1 2021.
- A 5-year average of -$35965.4 and a median of -$24000.0 in 2022 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2021 and 2022: Cash from Investing Activities plunged 231.53% in 2021, then soared 81.25% in 2022.
- Over 5 years, Cash from Investing Activities stood at -$49613.0 in 2021, then jumped by 51.63% to -$24000.0 in 2022, then jumped by 50.0% to -$12000.0 in 2023, then sank by 100.0% to -$24000.0 in 2024, then surged by 83.33% to -$4000.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$4000.0, -$24000.0, and -$16000.0 for Q1 2025, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2025 | -4,000.00 |
| Feb 28, 2025 | -4,000.00 |
| May 31, 2024 | -24,000.00 |
| May 31, 2024 | -24,000.00 |
| Feb 29, 2024 | -16,000.00 |
| Feb 29, 2024 | -16,000.00 |
| Nov 30, 2023 | -12,000.00 |
| Nov 30, 2023 | -12,000.00 |
| Aug 31, 2023 | -63,000.00 |
| Aug 31, 2023 | -63,000.00 |
| May 31, 2023 | -14,000.00 |
| May 31, 2023 | -14,000.00 |
| Feb 28, 2023 | -6,000.00 |
| Feb 28, 2023 | -6,000.00 |
| Nov 30, 2022 | -24,000.00 |
| Nov 30, 2022 | -24,000.00 |
| Aug 31, 2022 | -34,000.00 |
| Aug 31, 2022 | -34,000.00 |
| May 31, 2022 | -24,017.00 |
| May 31, 2022 | -24,017.00 |